BioSyent Inc.
BIOYF
$11.35
-$0.05-0.43%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 18.99% | 18.02% | -26.64% | 33.51% | -9.76% |
| Total Depreciation and Amortization | 110.95% | 119.31% | -13.77% | 19.97% | 4.49% |
| Total Amortization of Deferred Charges | 10.34% | -14.71% | 109.04% | -- | -- |
| Total Other Non-Cash Items | 456.27% | -150.45% | 303.41% | -95.38% | -224.20% |
| Change in Net Operating Assets | -2,551.08% | -105.01% | 1,918.56% | -105.00% | 140.17% |
| Cash from Operations | -9.10% | -21.77% | 24.43% | -19.87% | 601.16% |
| Capital Expenditure | 39.39% | -102.04% | -206.52% | 168.15% | 2.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -68.68% | 19.17% | 442.00% | 131.18% | -82.05% |
| Cash from Investing | 104.54% | -910.80% | 423.58% | 163.82% | -83.51% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 47.61% | -7,792.66% | -4.86% | -2.92% | -1.05% |
| Issuance of Common Stock | 466.67% | -- | -100.00% | 446.03% | -89.23% |
| Repurchase of Common Stock | 7.58% | -15,079.03% | 26.19% | 28.51% | 97.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.39% | -10.30% | 1.20% | -0.52% | -3.62% |
| Other Financing Activities | -23.62% | -10.43% | 4.96% | 3.97% | 3.82% |
| Cash from Financing | -401.39% | 323.24% | -3.97% | 4.82% | 56.31% |
| Foreign Exchange rate Adjustments | -105.67% | 416.85% | -274.51% | 202.00% | -900.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.81% | -390.53% | 97.08% | -12.14% | 367.90% |